期刊文献+

结节性硬化症的基因突变研究 被引量:1

Gene mutation detection for a patient with tuberous sclerosis complex
下载PDF
导出
摘要 目的研究1例中国汉族人结节性硬化症TSC1和TSC2基因的突变情况。方法采用聚合酶链反应(PCR)扩增该例结节性硬化症患者、家族中的正常人以及100名健康对照者的TSC1和TSC2基因的全部外显子,并进行DNA测序分析。结果该例患者TSC1基因第15外显子存在C.1884-1887del AAAG(P.Leu628Leu fs X23)移码突变,引起读码框移位,并在其后第23位氨基酸处提前出现终止密码子TGA。家族中的正常成员及100名无关正常对照未检测出该位点突变。结论 TSC1基因的新缺失突变C.1884-1887del AAAG可能是导致患者临床发病的主要原因,该突变为新突变。 Objective To identify pathogenic mutation of the TSC1 and TSC2 gene in a Chinese Han patient with tuberous sclerosis complex.Methods All the coding exons of TSC1 and TSC2 genes of the patient,unaffected members in the family and 100 unrelated population-matched controls,were amplified by polymerase chain reaction.The products were analyzed by sequencing.Result One frame-shift mutation C.1884-1887 del AAAG(P.Leu628 Leu fs X23) from the patient was detected in the exon 15 of the TSC1 gene causing a reading frame shift and an early termination codon TGA followed by 23 amino acids.This novel mutation was not found in unaffected family members and 100 unrelated healthy controls.Conclusion The novel frame-shift mutation C.1884-1887 del AAAG in the TSC1 gene may be the underlying cause of this case with tuberous sclerosis complex.
出处 《实用皮肤病学杂志》 2016年第3期168-170,共3页 Journal of Practical Dermatology
基金 国家自然科学基金资助项目(81201226)
关键词 硬化症 结节性 TSC1基因 TSC2基因 突变 Tuberous sclerosis complex TSC1 gene TSC2 gene Mutation
  • 相关文献

参考文献15

  • 1O'Callaghan FJ,Shiell AW,Osbome JP,et al.Prevalence of tuberous sclerosis estimated by capture-recapture analysis [J].Lancet,1998,351:1490.
  • 2Curatolo P,Bombardieri R,Jozwiak S.Tuberous sclerosis [J].Lancet,2008,372:657-668.
  • 3Tee AR,Fingar DC,Manning BD,et al.Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling [J].Proc Natl Acad Sci USA,2002,99:13571-13576.
  • 4Rosser T,Panigrahy A,McClintock W.The diverse clinical manifestations of tuberous sclerosis complex: a review [J].Semin PediatrNeurol,2006'13(1):27-36.
  • 5Krymskaya.VP.Tumour suppressors hamartin and tuberin: intrace- llular signalling [J].Cell Signal,2003,15(8):729-739.
  • 6Franz DN.Everolimus in the treatment of subependymal giant cell astrocytomas,angiomyolipomas,and pulmonary and skin lesions associated with tuberous sclerosis complex [J].Biologies,2013,7:211-221.
  • 7European Chromosomel6 Tuberous Sclerosis Consortium.Identification and characterization of the tuberous sclerosis gene on chromosome 16[J].Cell,1993,75(7):1305-1315.
  • 8Crino PB.mTOR: A pathogenic signaling pathway in developmental brain malformations [J].Trends Mol Med,2011,17(12):734-742.
  • 9Au KS,Williams AT,Roach ES,et al.Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States [J].Genet Med,2007,9(2):88-100.
  • 10Jones AC,Shyamsundar MM,Thomas MW,et ai.Comprehensive mutation analysis of TSCl and TSC2-and phenotypiccorrelationsi nl50 families with tuberous sclerosis [J].Am J Hum Gene,1999,64(5):1305-1315.

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部